Skip to main content
Proceedings (Baylor University. Medical Center) logoLink to Proceedings (Baylor University. Medical Center)
. 2019 Jan 24;32(1):63–64. doi: 10.1080/08998280.2018.1540759

Tuberculous cellulitis in an immunocompetent patient

Pejman Rabiei 1, Merve Hasanov 1, Bobak Akhavan 1, Gabriel M Aisenberg 1,
PMCID: PMC6442911  PMID: 30956584

Abstract

Mycobacterial skin infections are rare, with a wide spectrum of clinical features in immunocompromised individuals. Overall, they represent <2% of all forms of extrapulmonary tuberculosis. Tuberculous cellulitis is considered a skin manifestation of miliary tuberculosis. We present a case of tuberculous cellulitis in an immunocompetent patient.

Keywords: Biopsy, cellulitis, immunocompetent, Mycobacterium tuberculosis


Cutaneous tuberculosis is an uncommon chronic mycobacterial skin infection, comprising 1% to 2% of all extrapulmonary tuberculosis manifestations.1,2 Recent studies show that the incidence of cutaneous tuberculosis has increased in some areas, in part due to drug-resistant mycobacteria and the HIV epidemic.3 Tuberculous cellulitis is a rare variant of cutaneous tuberculosis that has been mostly reported in immunosuppressed patients.4 A combination of clinical findings, histology, acid-fast bacilli stain, culture, and polymerase chain reaction (PCR) assay can help clinicians in the diagnosis of tuberculous cellulitis. However, obtaining an appropriate sample significantly impacts the diagnostic yield.

CASE REPORT

An otherwise healthy 54-year-old man, who had emigrated from Mexico 15 years earlier, presented to our hospital with 1 week of worsening pain, redness, and swelling of the dorsum of his left hand. Nonhealing wounds with satellite crusting and verrucous lesions were noted on the fourth digit of his left hand. A few months prior, he had developed blisters on the volar proximal phalanx of his left fourth digit, for which he did not seek medical attention. Since then, he had experienced intermittent pain and swelling of his left hand. He reported a fish spine stick to the affected area 1 year before admission and an injury to the tip of the finger after a fall 9 months before presentation. He denied fever, chills, cough, and night sweats. His physical examination was unremarkable except for the skin findings. He reported being exposed to another individual with tuberculosis 5 years before admission, for which he had completed 2 months of a treatment he could not describe. He had a negative PPD test performed 3 years earlier. Serology for HIV was negative.

Empirical treatment with intravenous vancomycin followed by 10 days of oral clindamycin was administered. A punch biopsy of the skin lesion of his finger failed to display any organisms on cultures and hematoxylin and eosin, periodic acid Schiff, acid-fast bacilli, and Gomori’s methenamine silver stains. Histological findings included acanthosis, focal spongiosis, perivascular and interstitial dermal lymphocytes, and plasma cells but no granulomas.

Forty days later, the patient was readmitted with persistent erythema and worsening pain and skin discoloration (Figure 1). X-ray and magnetic resonance imaging of his left hand were concerning for osteomyelitis of the fourth digit phalanxes. Another punch biopsy was unremarkable. Debridement and irrigation of the affected digit followed, and a wedge of deep tissue was obtained for stain, culture, and PCR. The stain was positive for acid-fast bacilli. Treatment with ethambutol, clarithromycin, and rifampin was started for suspected Mycobacterium marinum infection. PCR for Mycobacterium tuberculosis was reported positive 3 weeks later. Isoniazid and pyrazinamide were added to the treatment. Two weeks later, the deep tissue culture grew M. tuberculosis and clarithromycin was discontinued. At that time, improvement of the skin lesions was noted (Figure 2). Chest x-ray was normal.

Figure 1.

Figure 1.

Left fourth digit showing a skin ulcer with satellite crusting and verrucous lesions.

Figure 2.

Figure 2.

Healing noted 2 weeks after starting therapy for tuberculosis infection.

DISCUSSION

Mycobacterial infection should always be considered in patients who present with stubborn and atypical cellulitis. Most reported cases of tuberculous cellulitis occurred in immunocompromised patients; this usually increases clinicians’ suspicion.5–7 Our patient presented with chronic inflammatory skin signs, history of injury to his finger, and no recognizable immune suppression.

Microbiological confirmation of tuberculous cellulitis remains challenging.8 The diagnostic yield depends on the selected method; on whether the form of cutaneous tuberculosis is paucibacillary or multibacillary; and on site selection, technique, and choice of transport media.8 Tuberculous cellulitis is considered a form of miliary tuberculosis and is usually multibacillary. Deep tissue biopsy and swab cultures have concordant results in 50% to 60% of samples in chronic skin infections.9–11 Though highly recommended in the assessment of chronic skin infections, deep tissue biopsy is relatively invasive, expensive, and may not be available in all settings.12 Though caseating granulomas are characteristic of tuberculous infection, they may be absent in some cases.13

There is no consensus regarding the recommended duration of therapy in cutaneous tuberculosis, though the miliary mechanism involved suggests that 9 months of therapy is appropriate.14,15 Deep tissue biopsy, ideally surgically obtained, is essential for the microbiological diagnosis of tuberculous cellulitis.

References

  • 1.Khadka P, Koirala S, Thapaliya J. Cutaneous tuberculosis: clinicopathologic arrays and diagnostic challenges. Dermatol Res Pract. 2018;2018:7201973. doi: 10.1155/2018/7201973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Daido-Horiuchi Y, Kikuchi Y, Kobayashi S, Fujii T, Oshima S, Kondo T. Tuberculous cellulitis in a patient with chronic kidney disease and polymyalgia rheumatica. Intern Med. 2012;51(22):3203–3206. doi: 10.2169/internalmedicine.51.8494. [DOI] [PubMed] [Google Scholar]
  • 3.Barbagallo J, Tager P, Ingleton R, Hirsch RJ, Weinberg JM. Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol. 2002;3(5):319–328. doi: 10.2165/00128071-200203050-00004. [DOI] [PubMed] [Google Scholar]
  • 4.Santos JB, Figueiredo AR, Ferraz CE, Oliveira MH, Silva P, Medeiros VL. Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects—part I. An Bras Dermatol. 2014;89(2):219–229. doi: 10.1590/abd1806-4841.20142334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sakiyama M, Maeshima H, Chishiki M, Horinosono H, Kawakubo Y. Tuberculous cellulitis: diseases behind cellulitis like erythema. Cutis. 2016;98(1):E14–E18. [PubMed] [Google Scholar]
  • 6.Taguchi R, Nakanishi T, Imanishi H, Ozawa T, Tsuruta D. A case of tuberculous cellulitis. Clin Med Insights Case Rep. 2015;8:11–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kim JE, Ko JY, Bae SC, Ro YS. Tuberculous cellulitis as a manifestation of miliary tuberculosis in a patient with malignancy-associated dermatomyositis. J Am Acad Dermatol. 2011;65(2):450–452. doi: 10.1016/j.jaad.2010.03.012. [DOI] [PubMed] [Google Scholar]
  • 8.Frankel A, Penrose C, Emer J. Cutaneous tuberculosis: a practical case report and review for the dermatologist. J Clin Aesthet Dermatol. 2009;2(10):19–27. [PMC free article] [PubMed] [Google Scholar]
  • 9.Pellizzer G, Strazzabosco M, Presi S, et al. Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med. 2001;18(10):822–827. doi: 10.1046/j.1464-5491.2001.00584.x. [DOI] [PubMed] [Google Scholar]
  • 10.van Mechelen M, van der Hilst J, Gyssens IC, Messiaen P. Mycobacterial skin and soft tissue infections: TB or not TB? Neth J Med. 2018;76(6):269–274. [PubMed] [Google Scholar]
  • 11.Bozkurt F, Gülsün S, Tekin R, Hoşoğlu S, Acemoğlu H. Comparison of microbiological results of deep tissue biopsy and superficial swab in diabetic foot infections. J Microbiol Infect Dis. 2011;1(3):122–127. doi: 10.5799/ahinjs.02.2011.03.0028. [DOI] [Google Scholar]
  • 12.Koba S, Okawa T, Misago N, et al. A case of tuberculous cellulitis lacking epithelioid granuloma. Acta Derm Venerol. 2013;93(5):596–597. doi: 10.2340/00015555-1548. [DOI] [PubMed] [Google Scholar]
  • 13.Siddiqui AR, Bernstein JM. Chronic wound infection: facts and controversies. Clin Dermatol. 2010;28(5):519–526. doi: 10.1016/j.clindermatol.2010.03.009. [DOI] [PubMed] [Google Scholar]
  • 14.van Zyl L, Du Plessis J, Viljoen J. Cutaneous tuberculosis overview and current treatment regimens. Tuberculosis (Edinb). 2015;95(6):629–638. doi: 10.1016/j.tube.2014.12.006. [DOI] [PubMed] [Google Scholar]
  • 15.Santos JB, Figueiredo AR, Ferraz CE, Oliveira MH, Silva P, Medeiros VL. Cutaneous tuberculosis: diagnosis, histopathology and treatment—part II. An Bras Dermatol. 2014;89(4):545–555. doi: 10.1590/abd1806-4841.20142747. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings (Baylor University. Medical Center) are provided here courtesy of Baylor University Medical Center

RESOURCES